Chronic Alcohol Exposure Disturbs Lipid Homeostasis at the Adipose Tissue-Liver Axis in Mice: Analysis of Triacylglycerols Using High-Resolution Mass Spectrometry in Combination with In Vivo Metabolite Deuterium Labeling by NC DOCKS at The University of North Carolina at Greensboro & Zhong, Wei
Chronic Alcohol Exposure Disturbs Lipid Homeostasis at the Adipose Tissue-Liver Axis in 
Mice: Analysis of Triacylglycerols Using High-Resolution Mass Spectrometry in 
Combination with In Vivo Metabolite Deuterium Labeling 
By: Xiaoli Wei, Xue Shi, Wei Zhong, Yantao Zhao, Yunan Tang, Wenlong Sun, Xinmin Yin, 
Bogdan Bogdanov, Seongho Kim, Craig McClain, Zhanxiang Zhou, Xiang Zhang 
Wei X, Shi X, Zhong W, Zhao Y, Tang Y, et al. (2013). Chronic Alcohol Exposure Disturbs 
Lipid Homeostasis at the Adipose Tissue-Liver Axis in Mice: Analysis of Triacylglycerols Using 
High-Resolution Mass Spectrometry in Combination with In Vivo Metabolite Deuterium 
Labeling. PLoS ONE 8(2): e55382. doi:10.1371/journal.pone.0055382 
Made available courtesy of Public Library of Science: 
http://dx.doi.org/10.1371/journal.pone.0055382  
 
***© The Authors. Published under a Creative Commons Attribution License (CC BY); 
http://creativecommons.org/licenses/by/3.0/  
Alcohol Consumption | Alcoholics | Alcohols | Deuterium | Fatty Acids | Fatty Liver Keywords: 
| Lipid Metabolism | Lipids  
 
 
Chronic Alcohol Exposure Disturbs Lipid Homeostasis at
the Adipose Tissue-Liver Axis in Mice: Analysis of
Triacylglycerols Using High-Resolution Mass
Spectrometry in Combination with In Vivo Metabolite
Deuterium Labeling
Xiaoli Wei1., Xue Shi1., Wei Zhong7, Yantao Zhao2, Yunan Tang2, Wenlong Sun1, Xinmin Yin1,
Bogdan Bogdanov1, Seongho Kim3, Craig McClain2,4,5,6, Zhanxiang Zhou7*, Xiang Zhang1*
1 Chemistry Department, University of Louisville, Louisville, Kentucky, United States of America, 2 Medicine Department, University of Louisville, Louisville, Kentucky,
United States of America, 3 Bioinformatics and Biostatistics Department, University of Louisville, Louisville, Kentucky, United States of America, 4 Pharmacology &
Toxicology Department, University of Louisville, Louisville, Kentucky, United States of America, 5 Alcohol Research Center, University of Louisville, Louisville, Kentucky,
United States of America, 6 Robley Rex Louisville VAMC, Louisville, Kentucky, United States of America, 7 Center for Translational Biomedical Research and Department of
Nutrition, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina, United States of America
Abstract
A method of employing high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling was
developed in this study to investigate the effects of alcohol exposure on lipid homeostasis at the white adipose tissue
(WAT)-liver axis in a mouse model of alcoholic fatty liver. In order to differentiate the liver lipids synthesized from the fatty
acids that were transported back from adipose tissue and the lipids synthesized from other sources of fatty acids, a two-
stage mouse feeding experiment was performed to incorporate deuterium into metabolites. Hepatic lipids extracted from
mouse liver, epididymal white adipose tissue (eWAT) and subcutaneous white adipose tissue (sWAT) were analyzed. It was
found that 13 and 10 triacylglycerols (TGs) incorporated with a certain number of deuterium were significantly increased in
alcohol induced fatty liver at two and four weeks of alcohol feeding periods, respectively. The concentration changes of
these TGs ranged from 1.7 to 6.3-fold increase. A total of 14 deuterated TGs were significantly decreased in both eWAT and
sWAT at the two and four weeks and the fold-change ranged from 0.19 to 0.77. The increase of deuterium incorporated TGs
in alcohol-induced fatty liver and their decrease in both eWAT and sWAT indicate that alcohol exposure induces hepatic
influx of fatty acids which are released from WATs. The results of time course analysis further indicate a mechanistic link
between adipose fat loss and hepatic fat gain in alcoholic fatty liver.
Citation: Wei X, Shi X, Zhong W, Zhao Y, Tang Y, et al. (2013) Chronic Alcohol Exposure Disturbs Lipid Homeostasis at the Adipose Tissue-Liver Axis in Mice:
Analysis of Triacylglycerols Using High-Resolution Mass Spectrometry in Combination with In Vivo Metabolite Deuterium Labeling. PLoS ONE 8(2): e55382.
doi:10.1371/journal.pone.0055382
Editor: Partha Mukhopadhyay, National Institutes of Health, United States of America
Received October 29, 2012; Accepted December 21, 2012; Published February 6, 2013
Copyright:  2013 Wei et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants 1R01GM087735, R01AA018844, 1RC2AA019385, P01AA017103, P30AA019360,
R01AA015970, R37AA010762, R01AA018016, R01AA018869, R01DK7071765, and Veteran’s Affairs. The funders have no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: z_zhou@uncg.edu (ZZ); xiang.zhang@louisville.edu (XZ)
. These authors contributed equally to this work.
Introduction
It has been understood that dietary fats are digested in the
intestinal epithelial cells, and then converted to triacylglycerols
(TGs). TGs are assembled with apolipoproteins to form chylomi-
crons which are transported into the blood stream via the lymph
system [1]. TGs are also synthesized by the liver where they are
packaged as very low-density lipoproteins (VLDL) and secreted
into the blood [1]. Upon arrival in the adipose and muscle tissues,
lipoprotein lipase cleaves TG into free fatty acids and glycerol.
Fatty acids are taken up by these tissues, and are used as energy
sources via oxidation in muscles, or re-assembled into TGs to store
excess energy in the white adipose tissue (WAT) [2]. Glycerol is
transported to liver or kidneys where it is converted into
dihydroxyacetone phosphate by glycerol kinase and glycerol-3-
phosphate dehydrogenase.
WAT plays an important role in regulation of whole body
energy homeostasis. WAT stores excess energy in the form of TG
under positive energy balance condition, and releases fatty acids
for energy generation under negative energy balance condition
[2]. However, excess fatty acid release from the WAT may cause
fatty acid overflux into the liver, leading to development of fatty
liver [3]. Fatty liver is frequently associated with both alcohol
abuse (alcoholic fatty liver, AFL) and obesity (nonalcoholic fatty
liver, NAFL). Although previous studies have demonstrated
similarities and differences in the pathogenesis of fatty liver
between alcohol abuse and obesity, increased fatty acid uptake has
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been suggested to be a common mechanism for AFL and NAFL
[4,5]. While hepatocytes isolated from both alcohol-fed and obese
rats showed an increased fatty acid uptake [6], further investiga-
tion is needed to provide direct evidence that fatty acids released
from the WAT are indeed deposited in the liver.
Clinical studies have demonstrated that lower fat mass
(lipodystrophy) was associated with higher liver fat in alcoholics
[7,8]. Animal models of AFL also showed that reduction of WAT
mass was associated with an increased fatty acid uptake by
hepatocytes [9–11]. Our study demonstrated that alcohol expo-
sure to mice caused more hepatic accumulation of TGs which
were labeled before alcohol exposure [12]. We also found that
alcohol exposure stimulated adipose lipolysis and fatty acid release
from WAT [12,13]. These data suggest that alcohol exposure may
cause an excess reverse fatty acid transport, thereby inducing fatty
liver. Therefore, the animal model of AFL could be an ideal model
to identify the importance of WAT in maintaining lipid
homeostasis at the WAT-liver axis. Further determination of
triacylglycerol homeostasis at the WAT-liver axis could reveal the
direct link between WAT and liver, an organ-organ interaction
mechanism, in the development of fatty liver.
The objective of this work was to use high-resolution mass
spectrometry in combination with metabolite deuterium labeling
to test our hypothesis that alcohol exposure disturbs lipid
homeostasis at the WAT-liver axis towards triacylglycerol epitomic
deposition in the liver. In order to differentiate the liver lipids
synthesized using fatty acids from other sources from that
synthesized using the fatty acids transported back from adipose
tissue, a two-stage feeding experiment was performed, where all
mice were first fed with deuterated water (2H2O) to ensure that the
lipids stored in adipose tissue are deuterium labeled (stage one).
The mice were then randomly grouped into two cohorts, the
control cohort and the test cohort. Mice in the test cohort were fed
an alcohol-containing liquid diet while mice in the control cohort
were pair-fed an isocaloric maltose dextrin control liquid diet. The
mice in both the control and test cohorts were then sacrificed at
different times (stage two). Metabolite extracts from mouse liver,
epididymal white adipose tissue (eWAT) and subcutaneous white
adipose tissue (sWAT) were analyzed using linear trap quadru-
pole–Fourier transform ion cyclotron resonance mass spectrom-
eter (LTQ-FTICR MS) via direct infusion electrospray ionization–
mass spectrometry.
Methods
Animals and Treatments
Male C57BL/6N mice were obtained from Harlan (Indianap-
olis, IN, USA). All the mice were treated according to the
experimental procedures approved by the University of Louisville
Animal Care and Use Committee. To label lipids in adipose
tissues, an approach using 2H2O as the metabolic tracer was
followed [14]. Mice at two months old were given an initial
priming dose of 99.8% 2H2O via an intraperitoneal injection to
achieve 2.5% of body water enrichment, followed by administra-
tion of 5% 2H2O in the drinking water for five weeks (stage one,
time point 0 week). The mice were then randomly grouped into
two cohorts, the control cohort and the test cohort, for a 4-week of
alcohol exposure (stage two). The test cohort was fed a modified
Lieber-DeCarli alcohol liquid diet which contained 1,000 kcal/L
calories, 34% from alcohol, 18% from protein, 34% from fat, and
14% from carbohydrate. The control cohort was fed a modified
Lieber-DeCarli control liquid diet which also contained
1,000 kcal/L calories with replacement of the alcohol calories by
isocaloric maltose dextrin. The alcohol-fed mice were free access
to the alcohol diet, while the pair-fed mice were given the control
diet in the same amount consumed by alcohol-fed mice in the
previous day. The liquid diet feeding was conducted for 2 (time
point of two weeks) or 4 (time point of four weeks) weeks. At the
end of each feeding time point, mice were anesthetized, and liver,
eWAT and sWAT tissues were collected from each mouse for
measuring lipid components labeled by deuterium. There were 5,
5, 3 and 5, 7, 5 mice at time point 0, 2, 4 weeks for the control
cohort and the test cohort, respectively.
Tissue Sample Preparation
Liver, eWAT and sWAT samples were weighed, homoge-
nized for 2 min and stored at –80uC until use. To extract
metabolites from the homogenized tissue, 100 mL of homoge-
nized tissue sample, 20 mL of butylatedhydroxytoluene (BHT)
mixture (50 mg BHT into 1 mL methanol) and 2.0 mL
chloroform–methanol (v/v = 2:1) were mixed and vortexed for
2 min followed by adding 420 mL of water and vortexing for
2 min. The mixture was then centrifuged at room temperature
at 2,000 rpm for 8 min. 400 mL of the organic phase (bottom)
was aspirated into another glass tube and dried using a nitrogen
evaporator. The dried sample was then dissolved into 200 mL of
chloroform–methanol (v/v = 2:1).
FT-MS and LTQ-MS/MS Analysis
The direct infusion experiments were performed on a hybrid
mass spectrometer, the so-called linear trap quadrupole – Fourier
transform ion cyclotron resonance mass spectrometer (LTQ-
FTICR MS or LTQ-FT MS) (Thermo Electron Corporation,
Bremen, Germany) equipped with a chip-based nano-electrospray
ionization (nESI) ion source (TriversaNanoMate) (Advion Biosci-
ences, Ithaca, NY, USA). The mass spectrometer was operated in
the positive ion mode. Each metabolite extract was measured for
5 min covering the m/z = 10021,600 range. The mass spectra
were recorded using the FTICR in profile mode and the resolving
power (RP) was set at 400,000 @ m/z = 400. The maximum ion
accumulation time was set at 1,000 ms. The ion optics was tuned
for the sodium adduct of tricaprylin ([C27H50O6+Na+]) at m/
z = 493.25 using the linear ion trap (LIT). The two most important
nESI parameters were as follows: the spray voltage = +1.8 kV and
the nitrogen gas pressure = 0.5 psi. The MS/MS spectrum of each
metabolite ion was acquired on the LTQ. The parameters were set
as follows: precursor ion m/z isolation window = 60.3, spectrum
accumulation time = 1 min. The normalized collision energy
(NCE) is a molecule dependent parameter and ranged from 16
to 40%.
Metabolite Quantification
The experimental data were processed using software package
MetSign [15]. After peak alignment, a contrast based method was
employed for normalization [16,17]. Both the Fisher’s exact test
and the pairwise two-tail t-test were used to study the concentra-
tion change of each metabolite between the two physiological
conditions. The parameters used during the analysis are as follows:
precursor ion m/z accuracy #5 ppm and the q-value for false
discovery rate (FDR) #0.2 [18]. Temporal analysis was performed
to study the correlation between time course trajectories measured
by Pearson’s correlation coefficient and the distance measured by
Fisher’s combined probability test [19,20].
Metabolite Identification
Metabolite identification was achieved in two sequential steps,
database search and MS/MS characterization. Such a metabolite
Adipose Dysfunction in Alcoholic Steatosis
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e55382
Figure 1. An example of identifying a deuterium incorporated metabolite using MS/MS information. The metabolite ion m/z value was
measured on FTICR-MS as 904.74066. (A) is the experimental MS/MS spectrum of non-deuterated metabolite. (B) is the matching result of the non-
deuterated metabolite between the experiment MS/MS spectrum and the theoretical MS/MS spectrum generated by Mass Frontier. The matched
fragment ions are highlighted in red and the not matched ions in black. (C) is the MS/MS spectrum of deuterium incorporated metabolite.
doi:10.1371/journal.pone.0055382.g001
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identification process meets the requirement of Level 2 metabolite
identification, i.e., putatively annotated metabolites [21]. The
metabolite database search was accomplished by the MetSign
software using the FTICR-MS data. Each of the measured
metabolite ion m/z value and isotopic peak profile were compared
to the corresponding theoretical information of metabolites
recorded in the MetSign database, which was composed of all
metabolites recorded in the Kyoto Encyclopedia of Genes and
Genomes, LIPID MAPS, and the Human Metabolome Database,
resulting in 43,245 records. Possible positive-mode adduct ions
include H+, Na+, K+, and NH4
+.
To narrow down the metabolite candidates generated by
database searching, the MS/MS spectra of metabolite peaks with
significant concentration changes between two sample cohorts
were acquired on LTQ-MS/MS. Each experimental MS/MS
spectrum was compared to the in silico MS/MS spectra of all
metabolite candidates using Mass Frontier 6.0 (Thermo Scientific,
FL, USA). The spectral similarity between the experimental MS/
MS spectrum and the in silico MS/MS spectrum of the metabolite
of interest was evaluated using Pearson’s correlation coefficient.
The metabolite candidate(s) with the best MS/MS spectrum
match was (were) considered as the metabolite giving rise to the
experimental spectrum.
Measurements of Liver Steatosis and Routine Parameters
Neutral lipids in the liver were detected by Oil red O staining.
Liver cryostat sections were cut at 7 mM, fixed with 10% formalin
for 5 min, and stained with Oil red O in 2-propynal solution for
10 min. Plasma alanine aminotransferase (ALT) activity and
triglyceride and cholesterol concentrations were determined using
Infinity Reagents (Thermo Scientific, Middletown, VA). Plasma
free fatty acids (FFA) were quantified using a FFA Quantification
Kit (BioVision, San Francisco, CA). Statistical differences were
analyzed by one-way ANOVA followed by Bonferroni post hoc
comparison. The data are presented as mean 6 SD and p values
less than 0.05 were considered as significant.
Results
Metabolite Identification
The metabolite initial assignment via database search was
achieved using high-resolution FTICR-MS data. Figure 1 is a
sample of putative identification of triacylglycerol TG(16:0/18:2/
20:4)[iso6]. The m/z value of this metabolite was measured as
904.7407 by FTICR-MS. By searching the 43,245 database
metabolites, this metabolite ion and its isotopic peak profile match
the corresponding theoretical information of metabolites
HMDB05391, HMDB10508, and HMDB13423 with adducts of
Na+, H+ and K+, respectively. The number of deuterium atoms
incorporated in these three metabolite candidates is 3, 5, and 6,
respectively. Therefore, the m/z values of the corresponding non-
deuterium incorporated metabolites of these three metabolite
candidates should be 901.7407, 899.7407 and 898.7407, respec-
tively. In order to confirm the initial assignment, LTQ-MS/MS
experiments were performed to acquire MS/MS spectra for each
of these metabolite ions. Figure 1A is the LTQ-MS/MS spectrum
of the metabolite ion with a measured m/z = 901.57. The
molecular structures of the candidate metabolites HMDB05391,
HMDB10508, and HMDB13423 were then uploaded into Mass
Frontier with corresponding adducts Na+, H+ and K+, respectively,
to generate in silico MS/MS spectra for each of these three
candidates. Each of the in silico spectra was then matched to the
experimental LTQ-MS/MS spectrum. The in silico MS/MS
spectrum of metabolite HMDB05391+Na+ has the best match
with a Pearson’s correlation coefficient of 0.9981 and therefore,
this metabolite was considered as the metabolite present in the
sample (Figure 1B).
It should be pointed out that Mass Frontier software can only
predict the m/z values of fragment ions, but not the fragment ion
abundance. It then matches the m/z values of the predicted
fragment ions to the m/z values of experiment mass spectrum.
Therefore, a high value of Pearson’s correlation coefficient only
refers to the matching quality of fragment ion m/z values between
an in silico MS/MS and an experiment MS/MS spectrum.
The incorporated deuterium atoms in a metabolite do not
significantly affect the metabolite fragmentation during MS/MS
analysis, resulting in similar MS/MS spectra between the
deuterium incorporated metabolite and the corresponding non-
deuterium incorporated metabolite. The only difference between
the MS/MS spectra is m/z values of the fragment ions that carry
deuterium atoms. The difference in the m/z values between the
corresponding fragment ions in the two spectra may range from
zero to the mass of all incorporated deuterium atoms. Figure 1C is
the LTQ-MS/MS spectrum of a deuterium incorporated version
of metabolite HMDB05391 with a measured metabolite ion m/
z = 904.80. The corresponding fragment ions between the
deuterium incorporated fragment ions and the non-deuterium
incorporated fragment ions are (904.80, 901.57), (887.99, 883.62),
(648.45, 645.39), (624.40, 621.37), (622.39, 619.44), (602.45,
599.44) and (600.46, 597.47). The number of incorporated
deuterium atoms in each fragment ion is 3, 3, 3, 3, 3, 3 and 3,
respectively. The spectral similarity between the spectrum of a
deuterium incorporated metabolite (Figure 1C) and the spectrum
of the corresponding non-deuterium incorporated metabolite
(Figure 1A) was evaluated using Pearson’s correlation coefficient,
after recognizing the pairs of fragment ions between the spectrum
of a deuterium incorporated metabolite and the spectrum of a
non-deuterium incorporated metabolite. The Pearson’s correla-
tion coefficient between the top 10 abundant fragment ions in the
two spectra displayed in Figures 1A and 1C is 0.8744, showing the
high similarity between these two spectra.
Statistical Significance Tests
Figure 2 depicts peak area distribution of triacylglycerol
TG(16:0/18:2/20:4)[iso6] at time two weeks among the samples
of the test and control cohorts. It can be seen that this molecule is
significantly increased with a 2.8-fold change in the test cohort
compared to its level in the control cohort. The fold change was
defined as the ratio of the average peak area of a metabolite
measured in the test cohort divided by the average peak area of the
same metabolite in the control cohort. The p-value of the pairwise
two-tail t-test is 1.461025.
Table 1 lists all of the metabolites identified with significant
concentration changes in liver between the control cohort and the
test cohort at two and four weeks. All of these metabolites were
identified as deuterium incorporated TGs even though all the
43,245 metabolites were searched for the metabolite identification.
Secondly, the deuterium incorporated TGs, 13 at 2 weeks and 10
at 4 weeks, were all increased in the test cohort with a 1.7 to 6.3-
fold change. Tables 2 list all of the metabolites identified with
significant concentration changes between the control cohort and
the test cohort at two and four weeks in the eWAT and sWAT.
These metabolites are all deuterium labeled and identified as TGs.
The number of deuterated TGs was more in the eWAT (10 TGs)
compared to the sWAT (4 TGs). All these deuteraed TGs were
reduced by alcohol exposure at either two weeks or four weeks
with a fold-change ranged from 0.19 to 0.77.
Adipose Dysfunction in Alcoholic Steatosis
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Temporal Analysis
Even though the statistical significance tests support the
hypothesis of reverse fatty acid transport, it is still necessary to
investigate the trajectory of each metabolite in the time course.
Figure 3 shows three sample time course trajectories in liver,
eWAT and sWAT, respectively. Figure 3A displays the time
course trajectory of triacylglycerol TG(16:0/18:2/20:4)[iso6]
with one 2H label and one Na+ as adduct ion in liver samples.
While this TG molecule was not significantly increased in
control cohort, it was significantly increased in test cohort at 2
weeks and a further elevation was found at 4 weeks. Figures 3B
and 3C show the time course trajectories of TG(16:0/16:1/
16:1)[iso3] with one 2H label and an adduct ion of Na+ in
eWAT samples, TG(16:0/16:0/18:1)[iso3] with one 2H label
and an adduct ion of Na+ in sWAT samples, respectively. In
contrast to the increase in the liver of test cohort, a decrease in
deuterium-labeled TGs was observed in both the eWAT and
sWAT of test cohorts. The deuterium-labeled TG(16:0/16:1/
16:1)[iso3] in eWAT significantly declined at 2 weeks and a
further decrease was found at 4 weeks. While deuterium-labeled
TG(16:0/16:0/18:1)[iso3] in sWAT significantly declined at 2
weeks, no further decrease was found at 4 weeks. Time course
changes for other deuterium-labeled TGs in liver and WAT
were listed in Table 1 and Table 2, respectively.
Figure 4 shows that the time course trajectory of triacylglycerol
TG(16:0/18:2/20:4)[iso6] without 2H label in liver samples of
control cohort and test cohort. This TG molecule represents
hepatic TGs which are synthesized from the dietary fats or from de
novo lipogenesis, because it did not incorporate any deuterium. In
the liver of control cohort, this TG molecule did not change at 2
weeks but increased at 4 weeks. Surprisingly, the test cohort
showed a remarkable increase at 2 weeks compared to time 0, and
a further increase at 4 weeks. The abundance of this TG molecule
in the test cohort was significantly higher than that in the control
cohort at both 2 and 4 weeks.
Alternations of Hepatic Neutral Lipid and WAT Mass
To determine an overall change in lipid homeostasis at the
liver-WAT axis, neutral lipid in the liver and WAT mass were
measured. As shown in Figure 5, oil red O staining of neutral
lipid on cryostat liver sections clearly demonstrated accumula-
tion of lipid droplets in the hepatocytes of alcohol-fed mice at 2
weeks. Further increases in number and size of the lipid
droplets were observed at 4 weeks. In contrast to neutral lipid
accumulation in the liver, WAT mass was significantly lower in
the alcohol-fed mice compared to the controls (Figure 6). The
weights of both eWAT and sWAT from control mice were
increased at 2 weeks and a further increase was found at 4
weeks. However, the weights of both eWAT and sWAT from
alcohol-fed mice did not change at either 2 weeks or 4 weeks,
leading to an increased difference between the control and
alcohol mice along the 4 weeks of experiment. The time course
changes in WAT to body weight ratio showed similar trends to
that of WAT mass.
Routine Parameters
Table 3 listed the results of routine parameters including body
weight, liver weight, liver to body weight ratio, and plasma ALT
activity and FFA concentration. The test cohort showed a lower
body weight but a higher liver weight, leading to a significant
increase in liver/body weight ratio at both 2- and 4-week time
points. The plasma ALT activity level, an indicator of liver injury,
was elevated in the test cohort at both time points. The plasma
triacylglycerol level was also increased in the test cohort at 4-week.
However, plasma cholesterol and FFAs was not affected by alcohol
exposure.
Discussion
TGs are the group of most abundant lipids in liver, eWAT and
sWAT. Analysis of the abundance changes of TGs is enough for us
to test our hypothesis. Therefore, the methanol/water phase of
metabolite extract from mouse tissues was discarded during the
process of metabolite extraction, while the organic phase was used
for analysis. It is possible that the regulations of other types of
metabolites are also changed besides TGs during the mouse
feeding period. However, the changes of these metabolites are not
in the scope of this study.
Biological Experiment Design
A two-stage animal feeding experiment was performed in this
study to differentiate the hepatic lipids synthesized from the
fatty acids transported back from adipose tissue from that
synthesized using fatty acids from de novo lipogenesis. It is
expected that majority of the lipids synthesized in the stage-one
experiment were incorporated with a certain number of
deuterium atoms, and most of them were transported and
stored in WAT. The purpose of the stage-two experiment was
to induce fatty liver in the test cohort and to use the mice in
the control cohort as reference to monitor the lipid concentra-
tion change in the mice of the test cohort.
During the stage-two experiment, lipids were continuously
synthesized in the mouse livers in both the test and the control
cohorts. The lipids synthesized from the uptake of dietary fats
should not incorporate any deuterium atoms, except a very small
fraction of naturally occurring deuterium in the dietary fats.
Therefore, two forms of lipids should be present in mouse liver:
deuterium incorporated lipids and non-deuterium incorporated
lipids. In case of the control cohort, the deuterium incorporated
lipids were synthesized during the stage-one experiment while the
Figure 2. Sample concentration changes of metabolite in two
different physiological conditions. The abundance test (pair-wise
two-tail t-test) shows that the concentration of this metabolite in the
test cohort is increased with a fold change of 2.8 and a p-value of
1.461025. This metabolite was further identified as TG(16:0/18:2/
20:4)[iso6] by MS/MS analysis.
doi:10.1371/journal.pone.0055382.g002
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Table 1. List of triacylglycerols in liver identified with significant concentration changes between the control cohort and the test
cohort at two and four weeks.
Time (Week) m/z p-value Fold change (T/C)a Metabolite common name Adduct ion No. 2H
2 878.7338 7.861023 2.1 TG(16:1/18:2/20:4)[iso6] H+ 1
2 902.7352 1.061024 8.1 TG(16:0/18:2/20:4)[iso6] Na+ 1
2 904.7407 1.461025 2.8 TG(16:0/18:2/20:4)[iso6] Na+ 3
2 907.7698 2.861023 2.8 TG(16:0/18:0/20:4)[iso6] Na+ 4
TG(16:0/20:4/20:4)[iso3] H+ 4
2 926.7360 6.961023 4.2 TG(16:0/20:4/20:4)[iso3] Na+ 1
TG(18:3/18:2/22:6)[iso6] H+ 1
2 927.7376 2.361023 1.9 TG(16:0/20:4/20:4)[iso3] Na+ 2
2 928.7407 5.761023 1.9 TG(16:0/20:4/20:4)[iso3] Na+ 3
2 929.7534 1.661022 1.7 TG(16:0/20:4/20:4)[iso3] Na+ 4
TG(18:3/18:2/22:6)[iso6] H+ 4
2 930.7666 3.161022 3.1 TG(18:3/18:3/20:0)[iso3] Na+ 1
2 952.7521 8.661023 6.3 TG(18:1/20:4/20:4)[iso3] Na+ 1
TG(18:3/20:4/22:6)[iso6] H+ 3
2 954.7666 9.161023 3.0 TG(20:4/18:1/22:6)[iso6] H+ 1
2 903.7797 7.261023 na b TG(16:0/18:0/18:0)[iso3] K+ 2
2 905.7533 4.861023 nab TG(16:0/18:2/20:4)[iso6] Na+ 4
TG(16:0/20:4/20:4)[iso3] H+ 2
4 902.7352 2.161023 3.8 TG(16:0/18:2/20:4)[iso6] Na+ 1
4 904.7407 4.461022 1.7 TG(16:0/18:2/20:4)[iso6] Na+ 3
4 926.7360 1.861023 2.7 TG(16:0/20:4/20:4)[iso3] Na+ 1
TG(18:3/18:2/22:6)[iso6] H+ 1
4 927.7376 3.861023 2.5 TG(16:0/20:4/20:4)[iso3] Na+ 2
4 928.7407 3.661022 1.7 TG(16:0/20:4/20:4)[iso3] Na+ 3
4 929.7534 2.261022 1.9 TG(16:0/20:4/20:4)[iso3] Na+ 4
TG(18:3/18:2/22:6)[iso6] H+ 4
4 930.7666 3.261022 2.8 TG(18:3/18:3/20:0)[iso3] Na+ 1
4 952.7521 2.861022 3.6 TG(18:1/20:4/20:4)[iso3] Na+ 1
TG(18:3/20:4/22:6)[iso6] H+ 3
4 953.7545 2.561022 2.7 TG(18:3/20:4/22:6)[iso6] H+ 4
4 954.7666 5.361023 3.3 TG(20:4/18:1/22:6)[iso6] H+ 1
aFold-change is the ratio of average peak area of a metabolite in the test cohort (T) to that in the control cohort (C).
bna refers to a metabolite that was detected only in the test cohort. Therefore, the values of fold change for these metabolites are not available.
doi:10.1371/journal.pone.0055382.t001
Figure 3. Sample time course trajectories of deuterium labeled triacylglycerols detected in liver, eWAT and sWAT samples. (A)
TG(16:0/18:2/20:4)[iso6] with one 2H label and one Na+ as adduct ion in liver samples. (B) TG(16:0/16:1/16:1)[iso3] with one 2H label and an adduct ion
of Na+ eWAT samples. (C) TG(16:0/16:0/18:1)[iso3] with one 2H label and an adduct ion of Na+ in sWAT samples.
doi:10.1371/journal.pone.0055382.g003
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non-deuterium incorporated lipids were synthesized in the stage-
two experiment.
Statistical Significance Tests
Compared to the levels of deuterium incorporated TGs in the
control cohort, the significant increase of the deuterium incorpo-
rated TGs in the test cohort of liver samples (Table 1) indicates
that extra deuterium incorporated fatty acids were used for the
synthesis of TGs in alcoholic fatty liver at 2 and 4 weeks. The only
source of the extra deuterium incorporated fatty acids is the
WATs, where the deuterium incorporated fatty acids were stored
in the form of TGs during the stage-one experiment. Therefore, a
reasonable explanation to the increase of deuterium incorporated
TGs in alcoholic fatty liver in the test cohort is that the deuterium
incorporated fatty acids were transported back from the WAT
after lipolysis due to alcohol consumption. Indeed, such an
explanation is further substantiated by the decrease of deuterated
TGs in eWAT and sWAT, respectively (Table 2). This supports
our hypothesis, i.e., alcohol consumption stimulates lipolysis in the
WAT of mice, leading to significant release of fatty acids, which
are transported back and deposited in the liver for the synthesis of
TGs.
Temporal Analysis
Figures 3A demonstrates that portions of the accumulated TGs
in fatty liver were synthesized using deuterium incorporated fatty
acids that were transported back from the WAT due to lipolysis,
while Figure 3B and 3C demonstrate a significant abundance
decrease of the deuterated TGs in eWAT and sWAT, respectively.
These results reveal a direct link between WAT fatty acid release
and hepatic TG deposition in the development of alcoholic fatty
liver. A previous study also demonstrated that diminishing lipid
storage function in WAT by over-expressing leptin-receptor b (lpr-
b) on the aP2-lpr-b promoter (aP2lepr-b transgene) in db/db mice
attenuated obesity after high fat feeding [22]. However, the
aP2lepr-b transgene significantly increased liver weight and
triglyceride concentrations, and accelerated the development of
diabetes. Therefore, WAT dysfunction in lipid storage could be an
important determinant in the pathogenesis alcoholic or nonalco-
holic fatty liver.
Figure 4 displays the time course trajectory of triacylglycerol
TG(16:0/18:2/20:4)[iso6] without any deuterium labeling in liver
samples. This TG molecule is synthesized by using fatty acids from
dietary source and/or hepatic de novo lipogenesis rather than by
using fatty acids transported back from the WAT. The time
dependent abundance of this metabolite in the test sample is
always higher than its abundance in the control sample at both 2
weeks and 4 weeks. These data indicate that fatty acids from the
WAT are not the sole source of TG synthesis, and fatty acids from
diet and/or de novo synthesis also contribute to the development of
alcoholic fatty liver.
Table 2. List of triacylglycerols in sWAT and eWAT identified with significant concentration changes between the control cohort
and the test cohort at two and four weeks.
WAT Time (Week) m/z p-value Fold change (T/C)a Metabolite common name Adduct ion No. 2H
sWAT 2 879.7446 2.161022 0.74 TG(16:1/18:2/20:4)[iso6] H+ 2
2 880.7507 3.961022 0.69 TG(16:0/18:1/18:2)[iso6] Na+ 1
4 826.7013 1.761023 0.28 TG(16:0/16:1/16:1)[iso3] Na+ 1
4 879.7446 1.561022 0.74 TG(16:1/18:2/20:4)[iso6] H+ 2
eWAT 2 826.7017 4.161024 0.38 TG(16:0/16:1/16:1)[iso3] Na+ 1
2 850.7013 1.361022 0.68 TG(16:1/16:1/18:2)[iso3] Na+ 1
2 854.7334 2.761023 0.58 TG(16:0/16:1/20:4)[iso6] H+ 1
2 855.7378 1.961022 0.70 TG(16:0/16:0/18:2)[iso3] Na+ 2
4 828.7174 1.661022 0.19 TG(16:0/16:1/16:1)[iso3] Na+ 3
4 854.7334 1.561022 0.54 TG(16:0/16:1/20:4)[iso6] H+ 1
4 855.7378 4.461022 0.48 TG(16:0/16:0/18:2)[iso3] Na+ 2
4 856.7482 2.261023 0.49 TG(16:0/16:0/18:1)[iso3] Na+ 1
4 879.7445 1.561022 0.73 TG(16:1/18:2/20:4)[iso6] H+ 2
4 880.7498 7.761023 0.77 TG(16:0/18:1/18:2)[iso6] Na+ 1
aFold-change is the ratio of average peak area of a metabolite in the test cohort (T) to that in the control cohort (C).
doi:10.1371/journal.pone.0055382.t002
Figure 4. Time course trajectory of triacylglycerol TG(16:0/
18:2/20:4)[iso6] without any deuterium labeling in liver
samples.
doi:10.1371/journal.pone.0055382.g004
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Figure 5. Time course changes of hepatic lipid content. (A) Hepatic neutral lipid detected by Oil red O staining of cryostat liver sections.
Alcohol exposure increased hepatic neutral lipid (lipid droplets) gradually along the 4 weeks of experiment. (B) Hepatic TG concentrations were
quantitatively measured. Data are expressed as mean 6 SD (n = 628). Statistical differences were analyzed by ANOVA followed by Bonferroni post hoc
comparison, and means without a common letter differ at p,0.05.
doi:10.1371/journal.pone.0055382.g005
Figure 6. Time course changes of WAT tissues. (A) WAT mass. The weights of both eWAT and sWAT in control mice increased gradually during
the 4 weeks of experiment. However, the alcohol-fed mice did not show weight change in both eWAT and sWAT at either 2 weeks or 4 weeks. (B)
WAT to body weight ratio (%). Data are expressed as mean 6 SD (n = 628). Statistical differences were analyzed by ANOVA followed by Bonferroni
post hoc comparison, and means without a common letter differ at p,0.05.
doi:10.1371/journal.pone.0055382.g006
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WAT Dysfunction and Fatty Liver
Time course changes in WAT weight (Figure 5) demonstrated
that WAT mass in control mice significantly increased along the 4
weeks of feeding. Surprisingly, the WAT mass of alcohol fed mice
did not changed at either 2 weeks or 4 weeks compared to time 0,
indicating a loss of the lipid storage function. A previous study has
reported that alcohol feeding to rats reduced total body fat content
due to an increase of TG turnover in rats, as indicated by a 2.3-
fold increase in TG degradation with no significant change in TG
synthesis [9]. Our previous report also showed that alcohol
exposure activates lipolysis pathways in WAT, thereby accelerat-
ing fatty acid release [12]. Adipose lipolysis is regulated positively
by catecholamine and negatively by insulin [23]. Previous studies
suggested that alcohol-increased lipolysis is most likely through
disturbing insulin signaling rather than enhancing catecholamine-
mediated lipolysis [9,12,24]. Insulin negatively regulates lipolysis,
and hosphodiesterase 4 (PDE4) and activating protein phosphatase
1 (PP1) mediate insulin signaling via reducing cellular cAMP level
and dephosphorylating hormone sensitive lipase (HSL), respec-
tively [23]. Although the adipose PDE4 was not affected in the
WAT of alcohol-fed rats [9], our previous study showed that PP1
protein level was reduced in the WAT of alcohol-fed mice [12].
We also found that chronic alcohol exposure up-regulated
negative regulators of insulin signaling, including phosphatase
and tensin homolog (PTEN) and suppressor of cytokine signaling 3
(SOC3). In addition to lipid storage dysfunction, alcohol exposure
also inhibited expression and secretion of adipokines including
adiponectin and leptin in WAT [25–27]. Both adiponectin and
leptin critically modulate hepatic lipid metabolism toward
reduction of lipid content in the liver. Normalizing plasma
adiponectin or leptin level was associated with attenuation of
alcoholic fatty liver [28–30]. Therefore, adipose tissue dysfunction
may contribute to the development of alcoholic fatty liver by
directly supplying fatty acids for hepatic TG synthesis or indirectly
disturbing adipokine regulation of hepatic lipid metabolism.
Alcohol-induced Hepatic Lipid Dyshomeostasis
Alcoholic exposure may disturb hepatic lipid metabolism in
multiple pathways, including fatty acid uptake, fatty acid
oxidation, de novo lipogenesis and lipid export [25,31]. The present
study demonstrated that alcohol exposure causes a reverse
transport of TGs from WAT to the liver. Liver plays a central
role in lipid metabolism, but it does not store lipid at physiological
condition. Balance between TG synthesis and export is a key
determent of hepatic lipid homeostasis [32,33]. While fatty acids
from either blood or de novo synthesis are converted to TGs which
are exported to the blood in the form of very low density
lipoproteins (VLDL) for use or storage by the peripheral organs.
Even though alcohol induces hepatic influx of fatty acids, fatty
liver should not be developed as long as the liver can efficiently
secrete TGs into the blood. Therefore, impaired VLDL secretion
should co-exist with hepatic fatty acid influx in the development of
alcoholic fatty liver. The present study shows that the liver of
alcohol-fed mice accumulated TGs synthesized by using fatty acids
of both deuterium labeled from WAT source and non-deuterium
labeled from dietary fats or de novo lipogenesis. These data suggest
that alcohol blunted lipid export. The authors believe that the
increased blood TG levels in the test cohort at 4 weeks may
indicate an impaired TG uptake from VLDL in WATs, rather
than an increased hepatic TG secretion. Indeed, our previous
study demonstrated that alcohol exposure significantly reduced the
rate of VLDL-TG secretion from the liver to the blood [11,13].
Disruption of VLDL secretion is likely an important mechanism
underlying alcoholic fatty liver, because improvement of VLDL
secretion was associated with attenuation of alcoholic fatty liver by
zinc, betaine or hepatocyte growth factor [11,34,35]. Further
investigations are required to determine the mechanisms of how
alcohol exposure suppresses lipid export function of the liver.
Conclusions
We used an analytical method of employing high-resolution
mass spectrometry in combination with metabolite deuterium
labeling for the analysis of triacylglycerol. A two-stage mouse
feeding schema was designed, where all mice were first fed with
deuterated water to label WAT TGs (stage one), followed by pair-
feeding an alcohol or isocaloric maltose dextrin control liquid diet
for two or four weeks. Hepatic lipids extracted from the livers,
eWAT and sWAT tissues were detected by FTICR–MS and
LTQ-MS/MS. All observations in this study, including the
increase of TGs in the test cohort of liver, the simultaneous
decrease of TGs in the test cohort of eWAT and sWAT, and the
agreement between the metabolomics data and the histological
data demonstrate that chronic alcohol exposure disturbs lipid
homeostasis at the adipose tissue-liver axis and therefore, support
our hypothesis, that is, alcohol consumption stimulates lipolysis of
the WAT and leads to an excess release of fatty acids which are
transported to the liver and deposited as TGs. Furthermore,
accumulation of TGs synthesized from fatty acids from dietary
source or de novo lipogenesis also contributes to the pathogenesis of
fatty liver.
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Table 3. Body weight, liver weight and plasma parameters of
the control cohort and the test cohort at two and four weeks.
2 weeks 4 weeks
Control Test Control Test
Body weight
(BW, g)
28.660.9 a 26.961.3 a 32.462.7 b 27.961.2 a
Liver weight (g) 1.0660.04 a 1.1660.05 b 1.1060.04 ab 1.3260.08 c
Liver/BW ratio (%) 3.6960.22 a 4.3360.30 b 3.4160.16 a 4.7760.21 c
ALT (U/L) 20.469.1 a 48.269.1 b 25.663.1 a 58.6612.6 b
Triacylglycerol
(mg/dL)
93.2610.4 a 130.5624.7 ab 110.4611.3 a 171.9647.7 b
Cholesterol
(mg/dL)
121.7619.6 107.1614.8 110.7610.3 101.4610.3
FFA (mg/dL) 0.3660.02 0.3160.05 0.3460.05 0.3360.07
Data are expressed as mean 6 SD (n = 628). Statistical differences were
analyzed by ANOVA followed by Bonferroni post hoc comparison, and means
without a common letter differ at p,0.05.
doi:10.1371/journal.pone.0055382.t003
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